Glycopatterns and Glycoproteins Changes in MCN and SCN: A Prospective Cohort Study

Abstract EN

Background.

Advances in imaging improve the detection of malignant pancreatic cystic including mucinous cystic neoplasm (MCN), intraductal papillary mucinous neoplasm (IPMN), and mucinous cystic adenocarcinoma (MCA), but the distinction between benign and malignant lesions remains a problem.

In an effort to establish glycopatterns as potential biomarkers for differential diagnosis between MCN and SCN, we systematically investigated the alterations of glycopatterns in cystic fluids for both SCN and MCN.

Methods.

Among the 75 patients enrolled, 37 were diagnosed as MCN and 38 as SCN based on histology.

Lectin microarray analysis was performed on each sample, and the fluorescence intensity was used to obtain the fold-change.

Then, mixed cyst fluids of MCN group and SCN group were cross bonded with magnetic particles coupled by Lectin STL and WGA, respectively.

Hydrophilic interaction liquid chromatography (HILIC) enrichment was performed, liquid chromatography (LC)/mass spectrometry (MS) analysis and bioinformatical analysis was conducted to find the differential glycoproteins between MCNs and SCNs.

Results.

Through analysis of lectin microarray between MCNs and SCNs, stronger lectin signal patterns were assigned to Lectin WFA, DBA, STL, WGA, and BPL; and weaker signal patterns were assigned to Lectin PTL-I, Con A, ACA, and MAL-I.

The glycoproteins were enriched by STL or WGA-coupled magnetic particles.

Furthermore, the 10 identified correspondding genes were found to be significantly elevated in the mucinous cystadenoma: CLU, A2M, FGA, FGB, FGG, PLG, SERPINA1, SERPING1, C5, C8A, and C9.

Bioinformatics analysis revealed that the above genes may activate the KEGG pathway: immune complement system.

Conclusion.

This study shows changes in glycopatterns and glycoproteins are associated with MCNs and SCNs.